{"id":51180,"date":"2025-07-29T07:38:40","date_gmt":"2025-07-29T11:38:40","guid":{"rendered":"https:\/\/stockmarketwatch.com\/stock-market-news\/market-reacts-to-novo-nordisk-guidance-cut-strong-earnings-from-paypal-and-pg-and-ongoing-us-china-trade-talks\/51180\/"},"modified":"2025-07-29T07:38:40","modified_gmt":"2025-07-29T11:38:40","slug":"market-reacts-to-novo-nordisk-guidance-cut-strong-earnings-from-paypal-and-pg-and-ongoing-us-china-trade-talks","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/market-reacts-to-novo-nordisk-guidance-cut-strong-earnings-from-paypal-and-pg-and-ongoing-us-china-trade-talks\/51180\/","title":{"rendered":"Market Reacts to Novo Nordisk Guidance Cut, Strong Earnings from PayPal and P&#038;G, and Ongoing US-China Trade Talks"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>Novo Nordisk (<a href=\"\/stock\/NVO\">NVO<\/a>) shares dropped 12% after the company cut its full-year sales forecast, citing lower-than-planned U.S. Wegovy sales due to compounded GLP-1RA treatments.<\/strong><\/li>\n<li><strong>PayPal (<a href=\"\/stock\/PYPL\">PYPL<\/a>) reported strong Q2 2025 earnings, with adjusted EPS of $1.40 against an estimate of $1.30, and net revenue of $8.29 billion, exceeding the $8.09 billion estimate.<\/strong><\/li>\n<li><strong>Procter &amp; Gamble (<a href=\"\/stock\/PG\">PG<\/a>) also surpassed Q4 2025 earnings expectations, posting adjusted EPS of $1.48 (estimate $1.43) and revenue of $20.9 billion (estimate $20.82 billion).<\/strong><\/li>\n<li><strong>Microsoft (<a href=\"\/stock\/MSFT\">MSFT<\/a>) is reportedly in serious negotiations to secure continuous access to key OpenAI technology, according to Bloomberg.<\/strong><\/li>\n<li><strong>A Chinese trade delegation was seen departing U.S. trade discussions in Stockholm, with talks aimed at extending a trade truce ahead of an August 12 deadline.<\/strong><\/li>\n<\/ul>\n<p>Pharmaceutical giant <strong>Novo Nordisk<\/strong> (<a href=\"\/stock\/NVO\">NVO<\/a>) experienced a significant <strong>12% drop in its shares<\/strong> after revising down its full-year sales forecast. The company now anticipates constant currency sales growth of <strong>+8% to +14%<\/strong>, a reduction from its previous guidance of <strong>+13% to +21%<\/strong>. This cut is primarily attributed to <em>lower-than-expected sales of its popular weight-loss drug Wegovy in the U.S.<\/em>, impacted by the rise of compounded GLP-1RA treatments. Despite the revised outlook, Novo Nordisk&#39;s Q1 2025 total revenue jumped 18% at constant exchange rates compared to Q1 2024, and operating profit increased by 20%. The company expects a rebound in Wegovy sales starting in June, following a U.S. Food and Drug Administration (FDA) deadline for compounding pharmacies to cease producing unauthorized copies of Wegovy and Ozempic.<\/p>\n<p>In other corporate news, <strong>PayPal<\/strong> (<a href=\"\/stock\/PYPL\">PYPL<\/a>) delivered a strong performance in its Q2 2025 earnings report, exceeding analyst expectations. The company announced an adjusted EPS of <strong>$1.40<\/strong>, outperforming the estimated <strong>$1.30<\/strong>. Net revenue for the quarter also came in higher than anticipated at <strong>$8.29 billion<\/strong>, compared to an estimate of <strong>$8.09 billion<\/strong>. Total Payment Volume (TPV) reached <strong>$443.55 billion<\/strong>, surpassing the estimated <strong>$429.44 billion<\/strong>.<\/p>\n<p>Consumer goods giant <strong>Procter &amp; Gamble<\/strong> (<a href=\"\/stock\/PG\">PG<\/a>) also reported robust Q4 2025 earnings, beating Wall Street forecasts. The company posted an adjusted EPS of <strong>$1.48<\/strong>, higher than the estimated <strong>$1.43<\/strong>. Revenue for the quarter was <strong>$20.9 billion<\/strong>, slightly above the <strong>$20.82 billion<\/strong> estimate. Looking ahead, <strong>P&amp;G<\/strong> sees its fiscal year adjusted EPS between <strong>$6.83 and $7.09<\/strong>.<\/p>\n<p>Meanwhile, <strong>Microsoft<\/strong> (<a href=\"\/stock\/MSFT\">MSFT<\/a>) is reportedly engaged in <em>serious negotiations to secure continuous access to critical OpenAI technology<\/em>, according to Bloomberg. This development highlights the ongoing strategic importance of artificial intelligence partnerships in the tech sector.<\/p>\n<p>On the geopolitical front, a <strong>Chinese trade delegation<\/strong> was observed departing U.S. trade discussions. These talks, held in Stockholm, aim to extend a 90-day trade truce between the two economic powerhouses, with an August 12 deadline approaching. The discussions are focused on preventing a return to higher tariffs and addressing broader trade imbalances.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways Novo Nordisk (NVO) shares dropped 12% after the company cut its full-year sales forecast, citing lower-than-planned U.S. Wegovy [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5775,33,5833,1807,6334,3744,6668,3785,7201,3822,7202,4390,7203,5043,5317,5657],"class_list":["post-51180","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-pharmaceuticals","tag-msft","tag-fda","tag-earnings","tag-novo-nordisk","tag-nvo","tag-paypal","tag-pg","tag-procter-gamble","tag-pypl","tag-consumer-staples","tag-us-china-trade","tag-tpv","tag-technology","tag-openai","tag-microsoft"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/51180","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=51180"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/51180\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=51180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=51180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=51180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}